Ji‐Hua Ren

2.4k total citations
51 papers, 1.3k citations indexed

About

Ji‐Hua Ren is a scholar working on Epidemiology, Molecular Biology and Hepatology. According to data from OpenAlex, Ji‐Hua Ren has authored 51 papers receiving a total of 1.3k indexed citations (citations by other indexed papers that have themselves been cited), including 29 papers in Epidemiology, 22 papers in Molecular Biology and 15 papers in Hepatology. Recurrent topics in Ji‐Hua Ren's work include Hepatitis B Virus Studies (23 papers), Hepatitis C virus research (12 papers) and Sirtuins and Resveratrol in Medicine (8 papers). Ji‐Hua Ren is often cited by papers focused on Hepatitis B Virus Studies (23 papers), Hepatitis C virus research (12 papers) and Sirtuins and Resveratrol in Medicine (8 papers). Ji‐Hua Ren collaborates with scholars based in China, Macao and Thailand. Ji‐Hua Ren's co-authors include Juan Chen, Ailong Huang, Sheng‐Tao Cheng, Hongzhong Zhou, Fang Ren, Weixian Chen, Wanyu Li, Na‐Na Tao, Xue-Fei Cai and Chunli Song and has published in prestigious journals such as PLoS ONE, Hepatology and Journal of Virology.

In The Last Decade

Ji‐Hua Ren

48 papers receiving 1.2k citations

Peers

Ji‐Hua Ren

EPIDE

HEPAT

Xue-Fei Cai China

Hongzhong Zhou China

Po‐Yuan Ke Taiwan

Marisa Granato Italy

Eman El‐Ahwany Egypt

Ilaria Carnevale Italy

Roberta Santarelli Italy

Chun‐Jung Lin Taiwan

Feng Ren China

Xue-Fei Cai China

Ji‐Hua Ren

356 ×0.6

EPIDE

438 ×0.8

80 ×0.3

193 ×0.8

HEPAT

149 ×0.7

Citations per year, relative to Ji‐Hua Ren Ji‐Hua Ren (= 1×) peers Xue-Fei Cai

Countries citing papers authored by Ji‐Hua Ren

Since Specialization

Citations

This map shows the geographic impact of Ji‐Hua Ren's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ji‐Hua Ren with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ji‐Hua Ren more than expected).

Fields of papers citing papers by Ji‐Hua Ren

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ji‐Hua Ren. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ji‐Hua Ren. The network helps show where Ji‐Hua Ren may publish in the future.

Co-authorship network of co-authors of Ji‐Hua Ren

This figure shows the co-authorship network connecting the top 25 collaborators of Ji‐Hua Ren. A scholar is included among the top collaborators of Ji‐Hua Ren based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ji‐Hua Ren. Ji‐Hua Ren is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Yang, Minli, Sheng‐Tao Cheng, Huiying Gu, et al.. (2025). RPL6 Interacts with HMGCS1 to Stabilize HIF‐1α by Promoting Cholesterol Production in Hepatocellular Carcinoma. Advanced Science. 12(38). e01373–e01373.

Cheng, Sheng‐Tao, Weixian Chen, Haijun Deng, et al.. (2025). Glutamate dehydrogenase 1-dependent α-ketoglutarate promotes hepatitis B virus transcription by modulating histone methylations on the covalently closed circular DNA minichromosome. Clinical and Molecular Hepatology. 31(3). 841–865. 2 indexed citations

Xu, Kexin, Na‐Na Tao, Sheng‐Tao Cheng, et al.. (2024). ZNF148 inhibits HBV replication by downregulating RXRα transcription. Virology Journal. 21(1). 35–35. 2 indexed citations

Ren, Ji‐Hua, Haibo Yu, Xin He, et al.. (2024). HOXA‐AS2 Epigenetically Inhibits HBV Transcription by Recruiting the MTA1‐HDAC1/2 Deacetylase Complex to cccDNA Minichromosome. Advanced Science. 11(24). e2306810–e2306810. 7 indexed citations

Ren, Ji‐Hua, Sheng‐Tao Cheng, Kexin Xu, et al.. (2024). Kinesin Family Member-18A (KIF18A) Promotes Cell Proliferation and Metastasis in Hepatocellular Carcinoma. Digestive Diseases and Sciences. 69(4). 1274–1286. 1 indexed citations

Xiao, Shungen, et al.. (2023). Research on the Influence of Geometric Structure Parameters of Eddy Current Testing Probe on Sensor Resolution. Sensors. 23(14). 6610–6610. 6 indexed citations

Ren, Fang, Junchi Hu, Yongjun Dang, et al.. (2023). Sphondin efficiently blocks HBsAg production and cccDNA transcription through promoting HBx degradation. Journal of Medical Virology. 95(3). e28578–e28578. 11 indexed citations

Liu, Xinyi, Yue Xiang, Kunlun He, et al.. (2023). Inhibiting cholesterol de novo synthesis promotes hepatocellular carcinoma progression by upregulating prostaglandin E synthase 2‐mediated arachidonic acid metabolism under high fatty acid conditions. Cancer Science. 115(2). 477–489. 8 indexed citations

Fan, Jie, Quanxin Long, Ji‐Hua Ren, et al.. (2022). Genome-wide association study of SARS-CoV-2 infection in Chinese population. European Journal of Clinical Microbiology & Infectious Diseases. 41(9). 1155–1163. 1 indexed citations

10.

Tao, Na‐Na, Ming Tan, Yuan Zhang, et al.. (2022). SIRT2 Promotes HBV Transcription and Replication by Targeting Transcription Factor p53 to Increase the Activities of HBV Enhancers and Promoters. Frontiers in Microbiology. 13. 836446–836446. 17 indexed citations

11.

Yu, Haibo, Sheng‐Tao Cheng, Yao Chen, et al.. (2022). Glutamate dehydrogenase 1 mediated glutaminolysis sustains HCC cells survival under glucose deprivation. Journal of Cancer. 13(3). 1061–1072. 19 indexed citations

12.

Zhang, Yuan, Liang Li, Sheng‐Tao Cheng, et al.. (2022). Rapamycin inhibits hepatitis B virus covalently closed circular DNA transcription by enhancing the ubiquitination of HBx. Frontiers in Microbiology. 13. 850087–850087. 6 indexed citations

13.

Tao, Na‐Na, Zhenzhen Zhang, Ji‐Hua Ren, et al.. (2020). Overexpression of ubiquitin-conjugating enzyme E2 L3 in hepatocellular carcinoma potentiates apoptosis evasion by inhibiting the GSK3β/p65 pathway. Cancer Letters. 481. 1–14. 19 indexed citations

14.

Cheng, Sheng‐Tao, Jieli Hu, Ji‐Hua Ren, et al.. (2020). Dicoumarol, an NQO1 inhibitor, blocks cccDNA transcription by promoting degradation of HBx. Journal of Hepatology. 74(3). 522–534. 98 indexed citations

15.

Cheng, Sheng‐Tao, Ji‐Hua Ren, Xue-Fei Cai, Hui Jiang, & Juan Chen. (2018). HBx-elevated SIRT2 promotes HBV replication and hepatocarcinogenesis. Biochemical and Biophysical Research Communications. 496(3). 904–910. 41 indexed citations

16.

Yu, Haibo, et al.. (2018). AGK2, A SIRT2 Inhibitor, Inhibits Hepatitis B Virus Replication In Vitro And In Vivo. International Journal of Medical Sciences. 15(12). 1356–1364. 48 indexed citations

17.

Cheng, Sheng‐Tao, Yuan Ding, Yi Liu, et al.. (2017). Interleukin-35 Level Is Reduced in Patients with Chronic Hepatitis B Virus Infection. International Journal of Medical Sciences. 15(2). 188–194. 14 indexed citations

18.

Tao, Na‐Na, Ji‐Hua Ren, Hua Tang, et al.. (2017). Deacetylation of Ku70 by SIRT6 attenuates Bax-mediated apoptosis in hepatocellular carcinoma. Biochemical and Biophysical Research Communications. 485(4). 713–719. 28 indexed citations

19.

Chen, Yong, Zhenzhen Zhang, Na‐Na Tao, et al.. (2016). SIRT6 Overexpression Potentiates Apoptosis Evasion in Hepatocellular Carcinoma via BCL2-Associated X Protein–Dependent Apoptotic Pathway. Clinical Cancer Research. 22(13). 3372–3382. 78 indexed citations

20.

Chen, Juan, Anthony W.H. Chan, Ka‐Fai To, et al.. (2013). SIRT2 overexpression in hepatocellular carcinoma mediates epithelial to mesenchymal transition by protein kinase B/glycogen synthase kinase-3β/β-catenin signaling. Hepatology. 57(6). 2287–2298. 171 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact